Mesenchymal-Stem-Cell-Based Strategies for Retinal Diseases.
Mesenchymal-Stem-Cell-Based Strategies for Retinal Diseases.
复制标题
基于间充质干细胞的视网膜疾病策略
DOI:
10.3390/genes13101901
复制
发表时间:
2022-10-19
期刊:
影响因子:
3.5
通讯作者:
Li, Xiaorong
中科院分区:
文献类型:
--
作者:
Chen, Xiteng;Jiang, Yuanfeng;Duan, Yanan;Zhang, Xiaomin;Li, Xiaorong
Retinal diseases are major causes of irreversible vision loss and blindness. Despite extensive research into their pathophysiology and etiology, pharmacotherapy effectiveness and surgical outcomes remain poor. Based largely on numerous preclinical studies, administration of mesenchymal stem cells (MSCs) as a therapeutic strategy for retinal diseases holds great promise, and various approaches have been applied to the therapies. However, hindered by the retinal barriers, the initial vision for the stem cell replacement strategy fails to achieve the anticipated effect and has now been questioned. Accumulating evidence now suggests that the paracrine effect may play a dominant role in MSC-based treatment, and MSC-derived extracellular vesicles emerge as a novel compelling alternative for cell-free therapy. This review summarizes the therapeutic potential and current strategies of this fascinating class of cells in retinal degeneration and other retinal dysfunctions.
登录
查看更多内容
影响因子:
--
作者:
Chen KH;Chen CH;Wallace CG;Yuen CM;Kao GS;Chen YL;Shao PL;Chen YL;Chai HT;Lin KC;Liu CF;Chang HW;Lee MS;Yip HK
通讯作者:
Yip HK
影响因子:
10.1
作者:
De Becker, Ann;Van Hummelen, Paul;Van Riet, Ivan
通讯作者:
Van Riet, Ivan
影响因子:
7.5
作者:
Ezquer M;Urzua CA;Montecino S;Leal K;Conget P;Ezquer F
通讯作者:
Ezquer F
影响因子:
4.4
作者:
Arnhold, Stefan;Heiduschka, Peter;Schraermeyer, Ulrich
通讯作者:
Schraermeyer, Ulrich
影响因子:
4.8
作者:
Adak S;Magdalene D;Deshmukh S;Das D;Jaganathan BG
通讯作者:
Jaganathan BG